Jason Beaubien

Jason Beaubien is NPR's Global Health and Development Correspondent on the Science Desk.

In this role, he reports on a range of health issues across the world including the mobilization of massive circumcision drives in Kenya; how Botswana, with one of the highest rates of HIV in the world, has managed to provide free, life-saving drugs to almost all who need them; and why Brazil's once model HIV/AIDS program is seen in decline.

Prior to moving into this assignment in 2012, Beaubien spent four years a NPR foreign correspondent covering Mexico, Central America and the Caribbean. From his base in Mexico City, Beaubien filed stories on politics in Cuba, hurricanes in Haiti, the FMLN victory in El Salvador, the world's richest man and Mexico's brutal drug war.

For his first multi-part series as the Mexico City correspondent, Beaubien drove the length of the U.S./Mexico border making a point to touch his toes in both oceans. The stories chronicled the economic, social and political changes along the violent frontier.

In 2002, Beaubien joined NPR after volunteering to cover a coup attempt in the Ivory Coast. Over the next four years, Beaubien worked as a foreign correspondent in sub-Saharan Africa, visiting 27 countries on the continent. His reporting ranged from poverty on the world's poorest continent, the HIV in the epicenter of the epidemic, and the all-night a cappella contests in South Africa, to Afro-pop stars in Nigeria and a trial of white mercenaries in Equatorial Guinea.

During this time, he covered the famines and wars of Africa, as well as the inspiring preachers and Nobel laureates. Beaubien was one of the first journalists to report on the huge exodus of people out of Sudan's Darfur region into Chad, as villagers fled some of the initial attacks by the Janjawid. He reported extensively on the steady deterioration of Zimbabwe and still has a collection of worthless Zimbabwean currency.

In 2006, Beaubien was awarded a Knight-Wallace fellowship at the University of Michigan to study the relationship between the developed and the developing world.

Beaubien grew up in Maine, started his radio career as an intern at NPR Member Station KQED in San Francisco and worked at WBUR in Boston before joining NPR.

Pages

Shots - Health News
3:16 pm
Thu June 13, 2013

Haiti Moves A Step Closer Toward Eradicating Elephantiasis

Boys at the L'Ecole Les Freres Clement elementary school in Jacmel, Haiti, line up to take deworming pills that protect against elephantiasis.
Maggie Steber for The Washington Post Getty Images

Originally published on Thu June 13, 2013 7:13 pm

Haiti has finally carried out a nationwide campaign to get rid of the parasitic worms that cause elephantiasis.

Haiti has waged other campaigns against the condition, characterized by severe disfiguration of the legs and arms. But until now, it has never managed to adequately reach residents of the chaotic capital Port-au-Prince.

Read more
Shots - Health News
4:17 pm
Tue June 4, 2013

Faces Of Drug-Resistant Tuberculosis

Originally published on Wed June 12, 2013 11:25 am

Forms of tuberculosis are emerging that are costly, difficult and at times, nearly impossible to treat. This new, worldwide threat is called multidrug-resistant TB, and it occurs when the bacteria no longer respond to the most common TB medications. Doctors have to turn, instead, to older, less effective drugs that can have devastating side effects such as hearing loss, blindness, aches and severe depression.

Read more
Shots - Health News
5:24 pm
Mon June 3, 2013

Love In The Time Of TB: A Young Family Fights An Ancient Foe

Oxana and Pavel Rucsineanu walk to the tuberculosis hospital in Balti, Moldova. Oxana and their new baby live in an apartment, but Pavel still has to stay at the TB ward, fighting for his life.
Jason Beaubien NPR

Originally published on Tue June 4, 2013 10:33 am

Oxana and Pavel Rucsineanu fell in love under the drug-induced haze of powerful tuberculosis medications. It was the summer of 2008. They were both in their late 20s, and they should have been in the prime of their lives.

Read more
Shots - Health News
9:08 am
Tue May 7, 2013

Saving Newborns: 'Kangaroo Care' Could Go A Long Way

A health worker weighs a Somali baby on scales at a medical clinic in Mogadishu. Babies in Somalia have the highest risk of dying within the first 24 hours after birth.
Carl de Souza AFP/Getty Images

Originally published on Wed May 8, 2013 9:46 am

In the developing world, a baby's first day of life is often the most perilous.

Roughly 3 million newborns die each year, the nonprofit Save the Children reported Tuesday. Most of these deaths occur in the first week of life, and more than 1 million babies pass away within 24 hours of being born.

Although the report calls for some big changes in health care systems to prevent newborn deaths, it also says that some simple, inexpensive things could save many lives.

Read more
Shots - Health News
3:00 am
Fri April 26, 2013

A $5.5 Billion Road Map To Banish Polio Forever

A health worker marks a baby's finger after giving her a polio vaccine in Moradabad, India.
Michaeleen Doucleff NPR

Originally published on Fri April 26, 2013 6:59 pm

Polio isn't going easily into the dustbin of history.

The world needs to push it in, throw down the lid and then keep an eye out to make sure it doesn't escape.

That's the gist of a new plan released Thursday by the World Health Organization and other foundations at a vaccine meeting in Abu Dhabi, United Arab Emirates.

It's a six-year, $5.5 billion program, and its goal is to wipe out polio for good.

Read more
Shots - Health News
7:39 pm
Wed April 10, 2013

A New Way To Make The Most Powerful Malaria Drug

An extract of sweet wormwood has been used in China for thousands of years to treat malaria, but being able to make mass quantities of the extract has been elusive, until now.
Sarah Cuttle Getty Images

Researchers in California described Wednesday their new method for mass-producing the key ingredient for the herbal drug artemisinin, the most powerful antimalarial on the market. Already, the French drugmaker Sanofi is ramping up production at a plant in Italy to manufacture the ingredient and the drug.

Global health advocates say they expect this new method of producing artemisinin will at last provide a stable supply of the drug and cut the overall cost of malaria treatment.

Read more
Science
6:17 pm
Wed April 10, 2013

Synthetic Malarial Drug Ingredient Could Cut Cost Of Treatment

Scientists have come up with a new way to produce the most common anti-malaria medicine currently on the market and a French pharmaceutical company is opening a new plant this week to manufacture it. The synthetic version of artemisinin is expected to stabilize the malaria medicine market and reduce the overall cost of malaria treatment.

Shots - Health News
11:38 am
Mon April 8, 2013

Dengue Fever Cases Have Been Seriously Underestimated

Dengue fever patients are treated in a hospital in Asuncion, Paraguay, in January.
Norberto Duarte AFP/Getty Images

A new paper in the journal Nature says scientists have been seriously underestimating the amount of dengue around the globe.

The study says there could be as many as 400 million dengue infections worldwide each year making it more prevalent than malaria. This is four times higher than the current dengue prevalence estimate of the World Health Organization.

Read more
Shots - Health News
6:20 pm
Tue April 2, 2013

How To Get Rid Of Polio For Good? There's A $5 Billion Plan

A child is immunized against polio at the health clinic in a farming village in northern Nigeria. The procedure involves pinching two drops of the vaccine into the child's mouth. For full protection, the child needs three doses, spaced out over time.
David Gilkey NPR

Originally published on Tue April 2, 2013 9:56 pm

Polio is on the verge of being eliminated. Last year there were just over 200 cases of polio, and they occurred in just two remote parts of the world — northern Nigeria and the rugged Afghan-Pakistan border region.

A new $5.5 billion plan being pushed by the World Health Organization strives to eliminate polio entirely, phase out vaccination campaigns and secure polio vaccine stockpiles in case the virus somehow manages to re-emerge.

If the effort is successful, polio would be just the second disease in human history, after smallpox, to be eliminated by medical science.

Read more

Pages